MBX Biosciences Inc (NASDAQ:MBX) shares, rose in value on Wednesday, June 18, with the stock price up by 1.78% to the previous day’s close as strong demand from buyers drove the stock to $10.28.
Actively observing the price movement in the last trading, the stock closed the session at $10.10, falling within a range of $9.93 and $10.52. Referring to stock’s 52-week performance, its high was $27.50, and the low was $4.81. On the whole, MBX has fluctuated by -15.39% over the past month.
With the market capitalization of MBX Biosciences Inc currently standing at about $343.61 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
The stock’s technical analysis shows that the price of MBX currently trading nearly -13.09% and -1.82% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.78, while the 7-day volatility ratio is showing 2.97% which for the 30-day chart, stands at 4.20%. Furthermore, MBX Biosciences Inc (MBX)’s average true range (ATR) is 0.92.
Data on historical trading for MBX Biosciences Inc (NASDAQ:MBX) indicates that the trading volumes over the past 10 days have averaged 0.21 and over the past 3 months, they’ve averaged 284.38K. According to company’s latest data on outstanding shares, there are 33.42 million shares outstanding.
Nearly 55.59% of MBX Biosciences Inc’s shares belong to company insiders and institutional investors own 54.36% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.75 million shares as on 2025-05-30, resulting in a short ratio of 18.21. According to the data, the short interest in MBX Biosciences Inc (MBX) stood at 2855.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 5.38 million. The stock has fallen by -44.22% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MBX stock heading into the next quarter.
